- U.S. Hemostats, used to control bleeding during surgical procedures, are increasingly essential components of modern surgical practice in the U.S. due to their ability to minimize blood loss, enhance surgical precision, and improve patient outcomes across a range of specialties
- The escalating demand for hemostats is primarily fueled by the rising number of surgical interventions, growing prevalence of chronic diseases, and an increasing shift toward minimally invasive procedures that require effective and rapid hemostatic solutions
- The U.S. hemostats market is also experiencing growth due to continued innovation by medical device companies, a well-established healthcare infrastructure, and the expanding use of hemostatic agents in outpatient and emergency care settings
- Absorbable hemostats are increasingly preferred in cardiovascular surgeries due to their biocompatibility and ability to perform effectively in confined surgical fields without the need for removal
- Cardiovascular surgery dominated the U.S. hemostats market with a revenue share of 32.1% in 2024, driven by the high incidence of heart-related conditions and the critical need for precise bleeding control during complex surgical procedures
